Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
The Lancet. Microbe
|
February 6, 2023
Ignoring SARS-CoV-2 testing performance during COVID-19
Christoph Buchta, Heinz Zeichhardt, Andrea Griesmacher, et al.
The Lancet. Microbe
|
November 17, 2023
Do not blindly trust negative diagnostic test results!
Christoph Buchta, Heinz Zeichhardt, Andreas Osterman, et al.
Antiviral Research
|
November 7, 2016
Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus
Sandra Pinkert, Babette Dieringer, Sabine Diedrich, et al.
International Journal of Medical Microbiology : IJMM
|
September 7, 2015
Does proficiency testing improve the quality of hantavirus serodiagnostics? Experiences with INSTAND EQA schemes
Jörg Hofmann, Hans-Peter Grunert, Oliver Donoso-Mantke, et al.
Plos One
|
February 6, 2013
Spiegelzymes: sequence specific hydrolysis of L-RNA with mirror image hammerhead ribozymes and DNAzymes
Eliza Wyszko, Maciej Szymański, Heinz Zeichhardt, et al.
Oligonucleotides
|
July 24, 2010
Rapid construction of adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30
Diana Rothe, Gisela Wajant, Hans-Peter Grunert, et al.
FEBS Letters
|
December 17, 2009
Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3
Denise Werk, Jesper Wengel, Suzy L Wengel, et al.
Journal of Molecular Biology
|
January 27, 2005
Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs
Steffen Schubert, Hans-Peter Grunert, Heinz Zeichhardt, et al.
Journal of Infection and Public Health
|
January 17, 2022
Evaluation of the diagnostic capacities for emerging arboviral diseases in the international network MediLabSecure from 2014 to 2018 - Importance of external quality assessments
Guillain Mikaty, Séverine Matheus, Oliver Donoso Mantke, et al.
FEBS Letters
|
August 12, 2008
Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3
Mariola Dutkiewicz, Hans-Peter Grunert, Heinz Zeichhardt, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
The Lancet. Microbe
|
February 6, 2023
Ignoring SARS-CoV-2 testing performance during COVID-19
Christoph Buchta, Heinz Zeichhardt, Andrea Griesmacher, et al.
The Lancet. Microbe
|
November 17, 2023
Do not blindly trust negative diagnostic test results!
Christoph Buchta, Heinz Zeichhardt, Andreas Osterman, et al.
Antiviral Research
|
November 7, 2016
Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus
Sandra Pinkert, Babette Dieringer, Sabine Diedrich, et al.
International Journal of Medical Microbiology : IJMM
|
September 7, 2015
Does proficiency testing improve the quality of hantavirus serodiagnostics? Experiences with INSTAND EQA schemes
Jörg Hofmann, Hans-Peter Grunert, Oliver Donoso-Mantke, et al.
Plos One
|
February 6, 2013
Spiegelzymes: sequence specific hydrolysis of L-RNA with mirror image hammerhead ribozymes and DNAzymes
Eliza Wyszko, Maciej Szymański, Heinz Zeichhardt, et al.
Oligonucleotides
|
July 24, 2010
Rapid construction of adeno-associated virus vectors expressing multiple short hairpin RNAs with high antiviral activity against echovirus 30
Diana Rothe, Gisela Wajant, Hans-Peter Grunert, et al.
FEBS Letters
|
December 17, 2009
Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3
Denise Werk, Jesper Wengel, Suzy L Wengel, et al.
Journal of Molecular Biology
|
January 27, 2005
Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs
Steffen Schubert, Hans-Peter Grunert, Heinz Zeichhardt, et al.
Journal of Infection and Public Health
|
January 17, 2022
Evaluation of the diagnostic capacities for emerging arboviral diseases in the international network MediLabSecure from 2014 to 2018 - Importance of external quality assessments
Guillain Mikaty, Séverine Matheus, Oliver Donoso Mantke, et al.
FEBS Letters
|
August 12, 2008
Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3
Mariola Dutkiewicz, Hans-Peter Grunert, Heinz Zeichhardt, et al.
Page
of 6